the tolerability of both drugs was good : 16 ( 76.2 % ) patients in the ceftriaxone group and 12 ( 63.2 % ) in the cefotaxime group had no adverse events , while in 5 and 7 patients , respectively , tolerability was considered satisfactory ( minor side effects , none of which required discontinuation or even reduction of dosage ) .
C0007561
ceftriaxone
C0007554
cefotaxime